Pharma Industry News
Printable Version   Email to a friend

New Year's Resolutions

Quit smoking. Lose weight. These two New Year's Resolutions top the list in the US every year. No wonder, with obesity and related diseases such as diabetes on the rise, and increasing restrictions on acceptable public smoking areas that make lighting up a challenge.

Obesity and smoking are the top threats to the nation's health, according to the 16th annual America's Health Rankings" (AHR) report, summarized in a USA Today article on 14 December 2005.

The AHR report assesses the nation's health on a state-by-state basis and examines influences on health, such as smoking and nutrition.

Although Americans' overall health has improved by 18.4% since 1990, the improvement rate is slowing down.

"In the 1990s, we were seeing a 1.5% increase year over year," according to Reed Tuckson, vice president of the United Health Foundation, which publishes the AHR report in partnership with the American Public Health Association and Partnership for Prevention. United Health Foundation is a non-profit research group established by UnitedHealth Group, a private health insurance and health services company, according to USA Today.

Smoking and Obesity Statistics

Since 2000, the average annual increase in national health has slipped to 0.3%, in large part because of smoking and obesity. Although the percentage of smokers has declined 30% overall since 1990, 20.8% of Americans still smoke.

"People are going to have to start making choices if our nation is going to reach its full potential," Tuckson said, according to USA Today. "Smoking remains the most important risk factor for the prevention of disease and premature death."

Obesity's upward trend makes it an equally worrying health risk - the incidence of obesity rose from 11.6% in 1990 to 23.1% last year for Americans aged 18 years and up, according to figures from the Centers for Disease Control and Prevention (CDC).

In the last year alone, 2.6% more Americans (1.5 million) are classified as obese, according to the CDC.

"The impact this will have on other diseases that are related to obesity, especially diabetes, which then is related to diseases like heart disease and kidney disease, is significant," Tuckson reported to USA Today. "What we can expect is that more people will be living with secondary disease. They will die sooner, and they will drive up health care costs."

Residents of 28 countries can expect more years of healthy living than US residents, Tuckson reportedly said. The US has 69.3 years, while Japan has 75 years (the longest health expectancy), followed by France (72 years), Germany (71.8 years) and the U.K. (70.6 years).

"What this is telling us is that we have not reached anywhere near our biological potential as human beings. We have a ways to go," Tuckson reported to USA Today.

Kicking the Habit in 2006

Quitting smoking is seldom easy. Each year, 34% of smokers try to quit, but only about 2.5% succeed, according to eMedicine Health. Nevertheless, 1 million Americans annually successfully quit smoking.

Apart from the health risks it poses, smoking is also becoming more expensive - and more inconvenient. Cigarette prices continue to rise, and more companies are severely restricting smoking areas or requiring employees who smoke to contribute more to their own health insurance. (See related article.)

Some health insurers will help pay for drugs to help subscribers stop smoking -check to see if yours does.

Drugs used to help people quit smoking include nicotine-replacement therapy and prescription drugs that may alleviate symptoms of nicotine withdrawal.

Drug Treatment

Nicotine Replacement Therapy replaces nicotine from cigarettes with nicotine from lozenges, chewing gum, a patch or a nasal spray.
Examples include Commit Lozenges, Nicorette Gum, Nicoderm C-Q Patch, Nicotrol Patch, and Nicotrol Nasal Spray.

Bupropion (Zyban SR), (also prescribed as an antidepressant under the brand name Wellbutrin), been found in some cases to help ease the withdrawal symptoms associated with quitting smoking.

Getting Help

Talk to your health practitioner about drugs and counseling options to help quit smoking.

Smokers often need support when trying to quit. To help locate a smoking cessation support group in your area, contact your local chapter of the American Lung Association.

These websites offer useful information about quitting smoking and the treatment of smoking-related diseases:

Lose Weight and Keep It Off

Over the past 20 years, obesity among adults in the US has risen sharply. In fact, 30% of adults aged 20 years and older are obese - over 60 million people - according to recent data from the National Center for Health Statistics (NCHS).

Younger people are also increasingly overweight. Since 1980, the percentage of young people who are overweight has more than tripled. Now, among children and teens aged 6-19 years, 16% (over 9 million young people) are considered overweight, according to figures from the NCHS.*

The epidemic of obesity has wide implications for over all health, as obesity increases the risk of many health conditions and diseases, including:

*Source: Centers for Disease Control and Prevention.

According to the CDC, although reducing the prevalence of obesity to <15% among adults by the year 2010 is a national health objective, the situation appears to be worsening.

Drug Treatment

There are a number of drugs approved by the FDA to assist with weight loss.

Appetite Suppressants work by stimulating the central nervous system which increases your heart rate and blood pressure and decreases your appetite. These drugs are used as a short-term supplement to diet and exercise in the treatment of obesity.
Appetite Suppressants include
Benzphetamine (Didrex)
Diethylpropion (Tenuate, Tenuate Dospan)
Mazindol (Sanorex, Mazanor)
Phendimetrazine (Adipost, Anorex-SR, Bontril, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex)
Phentermine (Adipex-P, Fastin, Ionamin, Obenix, Obephen, Oby-Cap, Phentercot, Phentride, Teramine, Zantryl)

Sibutramine (Meridia) is an appetite suppressant approved for long-term use.

Orlistat (Xenical) works by blocking about one-third of dietary fat from being absorbed, and is the most recently approved weight loss drug. Orlistat is also approved for long-term use.

Leptin and Weight Loss

Keeping the weight off is another challenge, but help from the hormone leptin may be available in the future, if recent studies prove correct.

According to researchers at Columbia University, leptin - a hormone involved in metabolism and hunger regulation - has been shown to help people who have lost weight to keep the weight off. To learn more about the recent study on leptin, click here.

Where to Start?

For many people struggling with obesity, the plethora of available weight loss methods -from diet books and over-the-counter weight loss products to custom slimming regimes -may be confusing and can be dangerous to a person's health, if not done under a doctor's supervision.

The best approach is to talk to your healthcare professional before embarking on any diet or exercise regime. Your doctor will also be able to advise you about prescription weight loss products that may help you to lose weight - and keep it off.

These websites offer useful information about the risks of obesity and finding ways to achieve a and maintain healthy weight:

Children and Obesity

Sources:
USA's health gets bad marks for smoking, obesity, USA Today, 14 December 2005.
eMedicine Health -Cigarette Smoking
Centers for Disease Control and Prevention - Overweight and Obesity
AtHealth.com: Prescription Medicine for the Treatment of Obesity

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
August 25, 2008
Audience: Neurologists, other healthcare professionals, patients[Posted 08/25/2008] FDA informed healthcare professionals of two...
August 21, 2008
Audience: Endocrinologists, cardiologists, other healthcare professionals, patients[Posted 08/21/2008] FDA informed healthcare...
August 18, 2008
Audience: Endocrinologists, other healthcare professionals, consumers[UPDATED 08/18/2008] Since issuing Information for...
August 14, 2008
Audience: Cardiologists, hospital risk managers [Posted 08/14/2008] Boston Scientific and FDA informed healthcare professionals...
More...
Latest Drug Information Updates

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

More...